A diverse set of oligomeric class II MHC-peptide complexes for probing T-cell receptor interactions

被引:30
|
作者
Cochran, JR [1 ]
Stern, LJ [1 ]
机构
[1] MIT, Dept Chem, Cambridge, MA 02139 USA
来源
CHEMISTRY & BIOLOGY | 2000年 / 7卷 / 09期
关键词
major histocompatibility complex; multivalent binding; oligomer; signal transduction; T-lymphocyte;
D O I
10.1016/S1074-5521(00)00019-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: T-cells are activated by engagement of their clonotypic cell surface receptors with peptide complexes of major histocompatibility complex (MHC) proteins, in a poorly understood process that involves receptor clustering on the membrane surface. Few tools are available to study the molecular mechanisms responsible for initiation of activation processes in T-cells. Results: A topologically diverse set of oligomers of the human MHC protein HLA-DR1, varying in size from dimers to tetramers, was produced by varying the location of an introduced cysteine residue and the number and spacing of sulfhydryl-reactive groups carried on novel and commercially available crosslinking reagents. Fluorescent probes incorporated into the cross-linking reagents facilitated measurement of oligomer binding to the T-cell surface. Oligomeric MHC-peptide complexes, including a variety of MHC dimers, trimers and tetramers, bound to T-cells and initiated T-cell activation processes in an antigen specific manner. Conclusion: T-cell receptor dimerization on the cell surface is sufficient to initiate intracellular signaling processes, as a variety of MHC-peptide dimers differing in intramolecular spacing and orientation were each able to trigger early T-cell activation events. The relative binding affinities within a homologous series of MHC-peptide oligomers suggest that T-cell receptors may rearrange in the plane of the membrane concurrent with oligomer binding.
引用
收藏
页码:683 / 696
页数:14
相关论文
共 50 条
  • [21] Class II MHC-peptide monomers antagonize CD4+ T cells
    Cochran, JR
    Stern, LJ
    FASEB JOURNAL, 2001, 15 (04): : A708 - A708
  • [22] The diversity of recognitions of MHC class II peptide complexes by T cell receptors
    Pu, Z
    Unanue, ER
    FASEB JOURNAL, 2002, 16 (05): : A1236 - A1236
  • [23] Affinity and kinetics of the interactions between an alpha beta T-cell receptor and its superantigen and class II-MHC/peptide ligands
    Khandekar, SS
    Brauer, PP
    Naylor, JW
    Chang, HC
    Kern, P
    Newcomb, JR
    Leclair, KP
    Stump, HS
    Bettencourt, BM
    Kawasaki, E
    Banerji, J
    Profy, AT
    Jones, B
    MOLECULAR IMMUNOLOGY, 1997, 34 (06) : 493 - 503
  • [24] The effect of peptide affinity for MHC class II on T-cell deletion.
    Peterson, DA
    Unanue, ER
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1278 - 1278
  • [25] T-cell activation is dependent on the intramolecular orientation within a MHC-peptide dimer
    Cochran, JR
    Stern, LJ
    FASEB JOURNAL, 2000, 14 (08): : A1391 - A1391
  • [26] Thermodynamics of T-cell receptor-peptide/MHC interactions: progress and opportunities
    Armstrong, Kathryn M.
    Insaidoo, Francis K.
    Baker, Brian M.
    JOURNAL OF MOLECULAR RECOGNITION, 2008, 21 (04) : 275 - 287
  • [27] QUANTITATION OF ANTIGEN-PRESENTING CELL MHC CLASS-II PEPTIDE COMPLEXES NECESSARY FOR T-CELL STIMULATION
    HARDING, CV
    UNANUE, ER
    NATURE, 1990, 346 (6284) : 574 - 576
  • [28] TOPOLOGY AND AFFINITY OF T-CELL RECEPTOR MEDIATED RECOGNITION OF PEPTIDE MHC COMPLEXES
    DAVIS, MM
    CHIEN, YH
    CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (01) : 45 - 49
  • [29] The crystal structure of a T cell receptor in complex with peptide and MHC class II
    Reinherz, EL
    Tan, KM
    Tang, L
    Kern, P
    Liu, JH
    Xiong, Y
    Hussey, RE
    Smolyar, A
    Hare, B
    Zhang, RG
    Joachimiak, A
    Chang, HC
    Wagner, G
    Wang, JH
    SCIENCE, 1999, 286 (5446) : 1913 - 1921
  • [30] The orientation of a T cell receptor to its MHC class II: Peptide ligands
    Hong, SC
    Sant'Angelo, DB
    Dittel, BN
    Medzhitov, R
    Yoon, ST
    Waterbury, PG
    Janeway, CA
    JOURNAL OF IMMUNOLOGY, 1997, 159 (09): : 4395 - 4402